Claims
- 1. A feline immunodeficiency virus which exhibits morphological and immunological properties of the retrovirus which is designated as FIV-Oma3 (SEQ ID NO:7).
- 2. An isolated and purified nucleic acid molecule encoding an feline immunodeficiency virus of claim 1.
- 3. An isolated and purified nucleic acid molecule which encodes a polypeptide selected from the group consisting of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14 and SEQ ID NO:15.
- 4. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:8.
- 5. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:9.
- 6. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:10.
- 7. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:11.
- 8. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:12.
- 9. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:13.
- 10. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:14.
- 11. The nucleic acid molecule of claim 3, wherein the polypeptide is SEQ ID NO:15.
- 12. A recombinant vector comprising the DNA sequence of SEQ ID NO:7.
- 13. The recombinant vector of claim 6 wherein the DNA sequence is selected from the group consisting of sequence encoding SEQ ID NO:8, sequence encoding SEQ ID NO:9, sequence encoding SEQ ID NO:10, sequence encoding SEQ ID NO:11, sequence encoding SEQ ID NO:12, sequence encoding SEQ ID NO:13, sequence encoding SEQ ID NO:14 and sequence encoding SEQ ID NO:15.
- 14. A polypeptide selected from the group consisting of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14 and SEQ ID NO:15.
- 15. The polypeptide of claim 14 which is SEQ ID NO:8.
- 16. A peptide consisting of fragments of 7-14 amino acids of the polypeptide of claim 14, wherein the fragments are cross reactive to at least two species of domestic or non-domestic cats.
- 17. A peptide consisting of fragments of 7-14 amino acids of the polypeptide of claim 15, wherein the fragments are cross reactive to at least two species of domestic or non-domestic cats.
Parent Case Info
[0001] This application is a divisional of U.S. application Ser. No. 09/238,303, filed on Jan. 28, 1999 which in turn claims priority of provisional application Ser. No. 60/072,927, filed on Jan. 29, 1998, which disclosures is incorporated herein by reference.
Government Interests
[0002] This invention was made with Government support under Grant No. RR09889-01-A1 awarded by the National Institutes of Health. The Government has certain rights in the invention.
Divisions (1)
|
Number |
Date |
Country |
Parent |
09238303 |
Jan 1999 |
US |
Child |
09946239 |
Sep 2001 |
US |